Riskpilot← Back to searchSign inGet full accessFOMED AB
ABActiveOrg 5590595970Vintervägen 26Business and other management consultancy activities · NACE 7020Est. 20161 employees
Revenue 2025
SEK 1,5M
0% vs 2024
EBITDA margin
-35.0%
-2410% vs 2024
Equity ratio
96.1%
Financial strength
Net profit 2025
SEK 7,8M
+1917% vs 2024
| Revenue | SEK 1,5M | +0% |
| EBITDA | SEK -527K | -2410% |
| Net profit | SEK 7,8M | +1917% |
| Total assets | SEK 9M | +633% |
| Equity | SEK 8,6M | +665% |
| Employees | 1 | — |
Legal name
FOMED AB
Org number
5590595970
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
19 april 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolagets verksamhet ska erbjuda tjänster och service inom ekonomisk och finansiell rådgivning samt bedriva därmed förenlig verksamhet. Därutöver ska bolaget äga och förvalta andelar i bolag. Handel med aktier och andra finansiella instrument.
Address
Vintervägen 26
Email
pdenneras@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 290 | 1 324 | 1 353 | 1 499 | 1 505 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 49 | 182 | 2 | −21 | −527 |
| Depreciation & amort. | −0 | −0 | −0 | −7 | −0 |
| EBIT | 49 | 182 | 2 | −28 | −527 |
| Net financials | 180 | −2 | 118 | 415 | 8 269 |
| Profit before tax | 228 | 274 | 219 | 387 | 7 804 |
| Tax | −11 | −60 | −28 | −0 | −0 |
| Net profit | 217 | 214 | 191 | 387 | 7 804 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 057 | 1 038 | 999 | 1 226 | 8 981 |
| Equity | 737 | 801 | 842 | 1 129 | 8 633 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 126 | 137 | 156 | 97 | 348 |
| Total debt | 126 | 137 | 156 | 97 | 348 |
EBITDA margin
-35.0%
This company
15.8%
Market median
-322% vs market
20212025
Equity ratio
96.1%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
90.4%
This company
18.4%
Market median
+391% vs market
20212025
Net profit margin
518.5%
This company
8.1%
Market median
+6301% vs market
20212025
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FOMED AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Pernilla Kristina Dennerås | Board of Directors | 0 companies |
| Niklas Eugén Dennerås | Deputy Board Member | 0 companies |